Integral Ad Science Holding Corp. (NASDAQ:IAS – Get Free Report)’s stock price shot up 3.3% on Wednesday . The stock traded as high as $10.13 and last traded at $10.04. 285,681 shares traded hands during trading, a decline of 67% from the average session volume of 878,924 shares. The stock had previously closed at $9.72.
Analysts Set New Price Targets
IAS has been the subject of several analyst reports. Truist Financial lowered their target price on shares of Integral Ad Science from $18.00 to $16.00 and set a “buy” rating for the company in a report on Wednesday, November 13th. Benchmark reissued a “hold” rating on shares of Integral Ad Science in a report on Thursday, November 14th. Scotiabank initiated coverage on shares of Integral Ad Science in a research note on Thursday, December 5th. They set a “sector perform” rating and a $10.00 price target on the stock. Piper Sandler decreased their price target on Integral Ad Science from $18.00 to $16.00 and set an “overweight” rating on the stock in a research report on Wednesday, November 13th. Finally, Craig Hallum reduced their target price on Integral Ad Science from $18.00 to $16.00 and set a “buy” rating for the company in a research report on Wednesday, November 13th. Four research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $15.18.
Integral Ad Science Stock Up 6.4 %
Integral Ad Science (NASDAQ:IAS – Get Free Report) last posted its quarterly earnings results on Tuesday, November 12th. The company reported $0.10 EPS for the quarter, beating analysts’ consensus estimates of $0.08 by $0.02. Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The company had revenue of $133.50 million during the quarter, compared to analyst estimates of $138.06 million. During the same period in the prior year, the business posted ($0.09) EPS. The firm’s revenue was up 11.0% compared to the same quarter last year. As a group, research analysts expect that Integral Ad Science Holding Corp. will post 0.26 EPS for the current fiscal year.
Institutional Investors Weigh In On Integral Ad Science
Several institutional investors and hedge funds have recently modified their holdings of IAS. Healthcare of Ontario Pension Plan Trust Fund purchased a new position in shares of Integral Ad Science during the second quarter valued at approximately $4,724,000. abrdn plc raised its position in Integral Ad Science by 12.5% in the 3rd quarter. abrdn plc now owns 2,147,656 shares of the company’s stock worth $23,216,000 after buying an additional 237,930 shares during the last quarter. JPMorgan Chase & Co. raised its holdings in shares of Integral Ad Science by 47.6% during the third quarter. JPMorgan Chase & Co. now owns 717,528 shares of the company’s stock valued at $7,756,000 after purchasing an additional 231,271 shares during the last quarter. Invenomic Capital Management LP lifted its holdings in shares of Integral Ad Science by 57.4% during the 3rd quarter. Invenomic Capital Management LP now owns 585,309 shares of the company’s stock valued at $6,327,000 after buying an additional 213,488 shares during the period. Finally, Rice Hall James & Associates LLC bought a new position in Integral Ad Science in the third quarter valued at about $1,795,000. 95.78% of the stock is owned by hedge funds and other institutional investors.
Integral Ad Science Company Profile
Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.
See Also
- Five stocks we like better than Integral Ad Science
- Health Care Stocks Explained: Why You Might Want to Invest
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- Following Congress Stock Trades
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- Investing In Automotive Stocks
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for Integral Ad Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Ad Science and related companies with MarketBeat.com's FREE daily email newsletter.